As shown in Figure 6, taken together these results indicate that tacrolimus has an inhibitory effect on RANKL expression in RA synoviocytes in both in vivo and in vitro experiments through its regulation of the JAK2-STAT3-SOCS3 pathway. Here, JAK2 is linked to rheumatoid arthritis.